Khare Satya R, Aprikian Armen, Black Peter, Blais Normand, Booth Chris, Brimo Fadi, Chin Joseph, Chung Peter, Drachenberg Darrel, Eapen Libni, Fairey Adrian, Fleshner Neil, Fradet Yves, Gotto Geoffrey, Izawa Jonathan, Jewett Michael, Kulkarni Girish, Lacombe Louis, Moore Ron, Morash Chris, North Scott, Rendon Ricardo, Saad Fred, Shayegan Bobby, Siemens Robert, So Alan, Sridhar Srikala S, Traboulsi Samer L, Kassouf Wassim
Department of Family Medicine, McGill University, Montreal, QC, Canada.
Department of Urology, McGill University Health Centre, Montreal, QC, Canada.
Urol Oncol. 2017 Jun;35(6):328-334. doi: 10.1016/j.urolonc.2016.12.003. Epub 2017 Jan 3.
Survival in patients with bladder cancer has only moderately improved over the past 2 decades. A potential reason for this is nonadherence to clinical guidelines and best practice, leading to wide variations in care. Common quality indicators (QIs) are needed to quantify adherence to best practice and provide data for benchmarking and quality improvement.
To produce an evidence- and consensus-based list of QIs for the management of bladder cancer.
A modified Delphi method was used to develop the indicator list. Candidate indicators were extracted from the literature and rated by a 27-member Canadian expert panel in several rounds until consensus was reached on the final list of indicators. In rounds with numeric ratings, a frequency analysis was performed.
A total of 86 indicators were rated, 52 extracted from the literature and 34 suggested by the panel. After iterative rounds of ratings and discussion, a final list of 60 QIs spanning several disciplines and phases of the cancer care continuum was developed.
This is the first study to comprehensively produce common QIs representing structure, process, and outcome measures in bladder cancer management. Though developed in Canada, these indicators can be used in other countries with slight modifications to track performance and improve care.
在过去20年中,膀胱癌患者的生存率仅有适度提高。造成这种情况的一个潜在原因是未遵循临床指南和最佳实践,导致护理差异很大。需要通用质量指标(QIs)来量化对最佳实践的遵循情况,并为基准测试和质量改进提供数据。
制定一份基于证据和共识的膀胱癌管理质量指标清单。
采用改良的德尔菲法制定指标清单。候选指标从文献中提取,并由一个由27名成员组成的加拿大专家小组进行多轮评分,直到就最终指标清单达成共识。在进行数字评分的轮次中,进行了频率分析。
共对86项指标进行了评分,其中52项从文献中提取,34项由专家小组提出。经过多轮评分和讨论,最终制定了一份包含60项质量指标的清单,涵盖癌症护理连续过程的多个学科和阶段。
这是第一项全面制定代表膀胱癌管理结构、过程和结果指标的通用质量指标的研究。尽管这些指标是在加拿大制定的,但在其他国家稍作修改后也可用于跟踪绩效和改善护理。